Showing results (921-930 of 2,413) with videos related to
Sort By:
Pageof 242
Journal of Medical Economics|August 19, 2014
Estimated medical cost reductions associated with use of novel oral anticoagulants vs warfarin in a real-world non-valvular atrial fibrillation patient populationAlpesh Amin, Michael Stokes, Dinara Makenbaeva, et al.Journal of Medical Economics|August 14, 2013
Comparison of therapy augmentation and deviation rates from the recommended once-daily dosing regimen between LDX and commonly prescribed long-acting stimulants for the treatment of ADHD in youth and adultsJuliana Setyawan, Paul Hodgkins, Annie Guérin, et al.Journal of Medical Economics|September 14, 2013
Primary vs secondary prophylaxis with pegfilgrastim for the reduction of febrile neutropenia risk in patients receiving chemotherapy for non-Hodgkin's lymphoma: cost-effectiveness analysesGregory Hill, Richard Barron, Kelly Fust, et al.Journal of Medical Economics|September 26, 2013
Prevalence and cost of hospital medical errors in the general and elderly United States populationsPeter J Mallow, Bhavik Pandya, Ruslan Horblyuk, et al.Journal of Medical Economics|September 27, 2013
The burden of preserved ejection fraction heart failure in a real-world Swedish patient populationJan Stålhammar, Lee Stern, Ragnar Linder, et al.Journal of Medical Economics|December 27, 2015
Value of innovation for hematologic malignanciesMarchetti MoniaJournal of Medical Economics|December 17, 2015
Frequency of skeletal-related events and associated healthcare resource use and costs in US patients with multiple myelomaEmily Nash Smyth, Ilaria Conti, James E Wooldridge, et al.Journal of Medical Economics|September 25, 2015
Real-world evaluation of TNF-inhibitor utilization in rheumatoid arthritisJ Harnett, D Wiederkehr, R Gerber, et al.Journal of Medical Economics|October 11, 2015
Cost-effectiveness of daclatasvir plus sofosbuvir-based regimen for treatment of hepatitis C virus genotype 3 infection in CanadaA Moshyk, M-J Martel, A A Tahami Monfared, et al.Journal of Medical Economics|October 13, 2015
Developing a tool to measure pharmacoeconomic outcomes of post-surgical pain management interventionsDeborah S Keller, Amy Smalarz, Eric M HaasPageof 242